Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study - Wikidata - wikimedia - TriplyDB

Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study

Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study

http://www.wikidata.org/entity/Q24803974

about

Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia.Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers.Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom.

P2860

Q33371808-CA9039D0-76CD-4294-B81E-AA982965FBFC Q33692833-EB20A286-A57F-4D5E-AB3D-569042BFB1FB Q37156300-7C116DC5-6FAF-43B9-9963-7ABA1B0CCAB5 Q42429095-9E855AB5-62AA-4A44-80DF-4964F1057267

P2860

Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study

http://www.wikidata.org/entity/Q24803974

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Prescription channeling of COX ...... ation-based case-control study

@ast

Prescription channeling of COX ...... ation-based case-control study

@en

Prescription channeling of COX ...... ation-based case-control study

@nl

type

label

Prescription channeling of COX ...... ation-based case-control study

@ast

Prescription channeling of COX ...... ation-based case-control study

@en

Prescription channeling of COX ...... ation-based case-control study

@nl

prefLabel

Prescription channeling of COX ...... ation-based case-control study

@ast

Prescription channeling of COX ...... ation-based case-control study

@en

Prescription channeling of COX ...... ation-based case-control study

@nl

P1433

Q24803974-FADACD21-BA4D-4D38-983B-AC1E755B9355

P1476

Q24803974-69023ED1-65CE-4A3C-9864-BC527D48E682

P2093

Q24803974-342681FB-9E49-46AC-B5C1-0FA1786B6514

Q24803974-3E63E9C5-9BEC-42E2-98C9-161DABBA3D17

Q24803974-61B71FD5-174F-4BED-A95D-726D4527E617

Q24803974-D4B5594E-5621-46E0-84FF-C46F1559438A

Q24803974-F1A27A0C-F666-49B1-AD98-2CEA2DD23A22

Q24803974-F98039C2-A2F3-400C-96ED-E8C57A5BA0BB

P2860

Q24803974-1319040E-16D3-4B56-B3EB-999303FDA8BA

Q24803974-2FA695F9-29AB-4599-94AA-3C0AE48EC075

Q24803974-3D511E5D-C2FE-49D1-B320-75D492686C66

Q24803974-5E0E5CDF-8F1C-4258-9A2A-6CA511470799

Q24803974-717F3BFD-49C1-492A-ABC5-732E161CD325

Q24803974-94788D43-3FBB-47AE-B114-02ADAE378808

Q24803974-B4E36E1D-6910-4855-A245-B1B50ECE0D84

Q24803974-CED8CC09-FFDC-4B3D-BA66-D06E8D5BEFFD

Q24803974-DBD43F08-1D4A-48C6-B6D0-9035934A5377

Q24803974-E1B8073D-2A42-4676-993C-3DDA6141900D

P2888

Q24803974-10FFF70F-469F-4D2B-AD96-BF0DD848C014

P304

Q24803974-164E5D49-3A7F-44A6-AF8A-E45EBC03CA12

P31

Q24803974-75071E9E-FCA7-4CE2-AE2E-357B42B45909

P356

Q24803974-FA8D98B9-6641-4C61-830C-94E4D765B859

P407

Q24803974-AC237763-05E0-45CD-9150-F75E18FA07F8

P433

Q24803974-29CC733D-8EDB-4D89-A03C-F3DE7696DDFB

P478

Q24803974-19A0A7D0-4505-4AF2-BC6C-50BE3966E1E5

P577

Q24803974-3AB6A77C-7A72-4B6E-89D6-28593F3CB017

P5875

Q24803974-E18920E3-89BD-4EE5-AA24-C370EB100C13

P6179

Q24803974-8600C85F-0C88-46B1-AD37-C839320C6F2B

P698

Q24803974-7B5ADCEF-37DF-4692-B0EF-1F7936F07F79

P921

Q24803974-C6B22550-F32F-4B44-8AAF-3BF96DE7844F

P932

Q24803974-8798DD9C-1871-4C87-A2DE-A1FA822CD7D7

P356

P1433

Arthritis Research and Therapy

P1476

Prescription channeling of COX ...... ation-based case-control study

@en

P2093

Jean-François Boivin

http://www.w3.org/2001/XMLSchema#string

Nicholas Moore

http://www.w3.org/2001/XMLSchema#string

Sean Zhao

http://www.w3.org/2001/XMLSchema#string

Sylvie Perreault

http://www.w3.org/2001/XMLSchema#string

Thierry Ducruet

http://www.w3.org/2001/XMLSchema#string

Yola Moride

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

A chronic disease score from automated pharmacy data.

Risk of cardiovascular events associated with selective COX-2 inhibitors.

The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec.

Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

Potential alternatives to COX 2 inhibitors.

Efficacy and safety of COX 2 inhibitors.

Celecoxib-associated torsade de pointes.

P2888

P304

R333-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR1488

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7991498

http://www.w3.org/2001/XMLSchema#string

P6179

1022899765

http://www.w3.org/2001/XMLSchema#string

P698

15743481

http://www.w3.org/2001/XMLSchema#string

P921

P932

1065326

http://www.w3.org/2001/XMLSchema#string